Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Salmon collagen pill may soothe sore knees in active adults

NCT ID NCT07119645

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a daily supplement made from salmon collagen (NT-II™) can reduce knee discomfort caused by activities like walking or climbing stairs. About 120 healthy adults aged 20 to 65 with mild to moderate knee pain will take either NT-II™ or a standard glucosamine-chondroitin supplement for 12 weeks. All study tasks are done from home using a phone app and mailed supplies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2025

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 20 to 65 years. * Self-reported, reproducible knee discomfort associated with any knee-loading activities for at least 3 months prior to screening. * Discomfort must occur in at least one knee during a nominated aggravating activity at least twice per week and subside with rest. * VAS rating of 30 mm to 75 mm during the past week for the nominated activity. * No current diagnosis of structural joint disease (e.g., osteoarthritis). * Engages in physical activity involving knee-loading movements at least twice weekly for 20+ minutes. * BMI between 20.0 and 32.5 kg/m². * In good general health with no significant medical comorbidities. * Able and willing to provide informed consent. * Capable of completing study procedures remotely using mobile technology. Exclusion Criteria: * Persistent knee pain at rest or recent acute lower-limb trauma. * Diagnosed structural or inflammatory joint disorders. * Current or recent physiotherapy targeting knee pain (within 6 months). * Allergy to fish or any study product ingredients. * Scheduled lower-limb surgery during the study period. * Other musculoskeletal disorders affecting ambulation. * Recent joint injections (within 3 months). * Use of joint supplements in the past 3 months. * Use of analgesics ≥3 days/week in the past 3 months. * NSAIDs/acetaminophen use is permitted with restrictions: * Not within 24 hours of blood sampling or VAS assessments. * Must be documented. * Chronic use of medications that affect musculoskeletal symptoms (e.g., muscle relaxants, gabapentinoids) unless infrequent (≤2x/week) and not within 24 hours of assessments. * Regular use of PPIs (\>3x/week in past month). * Systemic corticosteroids, immunosuppressants, or opioids within 4 weeks. * Unstable weight or significant recent dietary changes. * Significant medical conditions (e.g., cancer, hepatic/renal impairment, CVD, thyroid disease, diabetes). * Neurological, cognitive, or psychiatric disorders affecting participation. * Use of tobacco/nicotine or other substances. * Diagnosed sleep disorders. * Strict vegan diet or sedentary lifestyle. * Inability to swallow capsules. * Pregnant, breastfeeding, or planning pregnancy. * Women of childbearing potential not using contraception. * Participation in another interventional clinical trial.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Activity-related knee discomfort are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Pain Inflammation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Alethios Inc.

    RECRUITING

    San Francisco, California, 94109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.